arrow_back Back to Dashboard search Browse Jobs
AstraZeneca logo

AstraZeneca

✓ Verified Sponsor

Executive Director, Radiology & Theranostics 

🗓️ Posted 2026-09-02 2 Locations Full-time Hybrid Healthcare Medical

Company shared salary

NA

Market rate

10,000 GBP–16,666 GBP/mo (120,000 GBP–199,992 GBP/yr)

Based on similar roles (title + domain + location).

About the Company

Lead an integrated global Radiology & Theranostics organization spanning translational radiology, computational radiology, medical imaging, medical physics, nuclear medicine and translational science . This role will set and execute imaging strategy from preclinical through late clinical development, predominantly in oncology across solid tumors and hematologic malignancies and across therapy modalities, with a dditional support for trials beyond oncology. Key deliverables include development of imaging-based biomarkers for patient selection, target validation, pharmacodynamic assessment and treatment endpoints. Why this role Radiology is critical to diagnosing, staging and monitoring disease, but remains underused as a biomarker in drug development. Integrating radiology with pathology, proteomics, liquid biopsy and clinical data can accelerate endpoint development, patient-selection technologies, target validation and biomarker discovery. The longer-term opportunity is to use radiology and laboratory data to inform the right target, modality, dose, regimen and endpoint- ultimately improving patient outcomes. Competitors are already developing radiology-led multimodal biomarker platforms, making an enterprise-wide imaging strategy essential to strengthen delivery, science and innovation across the pipeline. Location: Gaithersburg MD or Kendall Square MA

Responsibilities

  • ● Define and execute the enterprise strategy for Radiology & Theranostics across the oncology portfolio, from preclinical development through late-stage clinical trials.
  • ● Establish a unified operating model, governance and investment roadmap for global imaging capabilities.
  • ● Lead imaging strategy for clinical development and pivotal trials, including patient selection, target validation, pharmacodynamic assessment, response assessment, endpoint selection and regulatory alignment.
  • ● Advance imaging-based biomarkers and radiomics for patient selection, pharmacodynamics, treatment endpoints and biomarker discovery.
  • ● Earlier, consistent integration of imaging into preclinical, clinical development and indication plans.
  • ● Lead Theranostics and Radioconjugate imaging strategy from preclinical development through Phase III, including dosimetry and study design.
  • ● Integrate PET, nuclear medicine, medical physics and translational science capabilities, including external academic collaborations.
  • ● Ensure imaging strategies are incorporated early into asset and indication plans across solid tumor , hematologic malignancy and selected non-oncology trials.
  • ● Represent the function in senior governance, business-development evaluations and interactions with regulators and external experts.
  • ● Recruit, develop and retain a high-performing, multidisciplinary global organization. Leadership scope The role is expected to provide strategic oversight across:
  • ● Translational Radiology: clinical development imaging strategy, radiographic endpoints and imaging-based biomarkers from preclinical through late clinica l development
  • ● Computational Radiology: radiomics, imaging AI and multimodal biomarkers
  • ● Medical Imaging, Medical Physics & Translational Science: Theranostics , Radioconjugate and dosimetry
  • ● Regional and external capabilities: including China and EU collaborations Measures of success
  • ● One aligned Radiology & Theranostics strategy and governance model.
  • ● Earlier, consistent integration of imaging into development plans.
  • ● Increased use of validated imaging endpoints and biomarkers.
  • ● Scalable radiomics data and AI infrastructure.
  • ● Strong Theranostics and R adioconjugate development capabilities.
  • ● Reduced duplication and improved collaboration across organizational boundaries. Experience Required
Credential Requirements for United Kingdom

Requirements shown are for Indian professionals relocating to United Kingdom.

🔴

PLAB 1 + PLAB 2

General Medical Council

Must have to work
Cost: GBP 1,000–2,000 Timeline: 6–18 months
🔴

NMC CBT + OSCE

Nursing and Midwifery Council

Must have to work
Cost: GBP 1,000–2,000 Timeline: 6–12 months
🔴

GPhC OSPAP

General Pharmaceutical Council

Must have to work
Cost: GBP 6,000–10,000 Timeline: 1 year
🔴

GDC ORE Part 1 + Part 2

General Dental Council

Must have to work
Cost: GBP 2,000–4,000 Timeline: 1–2 years